Grape King Bio Ltd (TPE: 1707)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
142.00
+2.00 (1.43%)
Sep 12, 2024, 1:30 PM CST

Grape King Bio Statistics

Total Valuation

Grape King Bio has a market cap or net worth of TWD 21.04 billion. The enterprise value is 18.34 billion.

Market Cap 21.04B
Enterprise Value 18.34B

Important Dates

The next estimated earnings date is Tuesday, November 12, 2024.

Earnings Date Nov 12, 2024
Ex-Dividend Date Jun 20, 2024

Share Statistics

Grape King Bio has 148.14 million shares outstanding. The number of shares has increased by 0.08% in one year.

Shares Outstanding 148.14M
Shares Change (YoY) +0.08%
Shares Change (QoQ) -0.24%
Owned by Insiders (%) 13.02%
Owned by Institutions (%) 21.60%
Float 113.90M

Valuation Ratios

The trailing PE ratio is 14.90.

PE Ratio 14.90
Forward PE n/a
PS Ratio 1.94
PB Ratio 2.20
P/FCF Ratio 20.69
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.27, with an EV/FCF ratio of 18.03.

EV / Earnings 12.91
EV / Sales 1.69
EV / EBITDA 6.27
EV / EBIT 7.42
EV / FCF 18.03

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 1.69.

Current Ratio 1.36
Quick Ratio 1.14
Debt / Equity 1.69
Debt / EBITDA 0.06
Debt / FCF 0.18
Interest Coverage 829.69

Financial Efficiency

Return on equity (ROE) is 20.01% and return on invested capital (ROIC) is 14.14%.

Return on Equity (ROE) 20.01%
Return on Assets (ROA) 10.04%
Return on Capital (ROIC) 14.14%
Revenue Per Employee 21.67M
Profits Per Employee 2.84M
Employee Count 501
Asset Turnover 0.71
Inventory Turnover 3.00

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -8.09% in the last 52 weeks. The beta is 0.47, so Grape King Bio's price volatility has been lower than the market average.

Beta (5Y) 0.47
52-Week Price Change -8.09%
50-Day Moving Average 142.86
200-Day Moving Average 152.85
Relative Strength Index (RSI) 48.76
Average Volume (20 Days) 206,186

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Grape King Bio had revenue of TWD 10.86 billion and earned 1.42 billion in profits. Earnings per share was 9.53.

Revenue 10.86B
Gross Profit 8.49B
Operating Income 2.44B
Pretax Income 2.62B
Net Income 1.42B
EBITDA 2.85B
EBIT 2.44B
Earnings Per Share (EPS) 9.53
Full Income Statement

Balance Sheet

The company has 4.18 billion in cash and 183.48 million in debt, giving a net cash position of 4.00 billion or 26.99 per share.

Cash & Cash Equivalents 4.18B
Total Debt 183.48M
Net Cash 4.00B
Net Cash Per Share 26.99
Equity (Book Value) 10.87B
Book Value Per Share 64.64
Working Capital 1.41B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.63 billion and capital expenditures -615.57 million, giving a free cash flow of 1.02 billion.

Operating Cash Flow 1.63B
Capital Expenditures -615.57M
Free Cash Flow 1.02B
FCF Per Share 6.86
Full Cash Flow Statement

Margins

Gross margin is 78.16%, with operating and profit margins of 22.51% and 13.09%.

Gross Margin 78.16%
Operating Margin 22.51%
Pretax Margin 24.13%
Profit Margin 13.09%
EBITDA Margin 26.22%
EBIT Margin 22.51%
FCF Margin 9.37%

Dividends & Yields

This stock pays an annual dividend of 6.90, which amounts to a dividend yield of 4.93%.

Dividend Per Share 6.90
Dividend Yield 4.93%
Dividend Growth (YoY) n/a
Years of Dividend Growth 1
Payout Ratio 71.95%
Buyback Yield -0.08%
Shareholder Yield 4.85%
Earnings Yield 6.71%
FCF Yield 4.83%
Dividend Details

Stock Splits

The last stock split was on September 15, 2005. It was a forward split with a ratio of 1.0205.

Last Split Date Sep 15, 2005
Split Type Forward
Split Ratio 1.0205